Mossler Mark 4
4 · C4 Therapeutics, Inc. · Filed Feb 18, 2025
Insider Transaction Report
Form 4
Mossler Mark
Chief Accounting Officer
Transactions
- Tax Payment
Common Stock
2025-02-14$3.18/sh−1,586$5,043→ 18,204 total
Footnotes (1)
- [F1]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person.